Clinical trial
Super Hypofractionated Irradiation for Whole Breast Treatment: a Prospective, Single-arm Trial
NCT04926766 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Super Hypofractionated Irradiation for Whole Breast Treatment: a Prospective, Single-arm Trial
- Lead sponsor
- Ruijin Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 23, 2021
- Completion date
- July 10, 2028
- Enrollment
- 217 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer